Bayer: Phase I trial results from Parkinson’s cell therapy positive
Bayer https://www.reuters.com/markets/companies/BAYGn.DE” target=”_blank” rel=”noopener”>(BAYGn.DE) subsidiary BlueRock has become the first company to report initial success treating Parkinson’s disease in humans using an experimental stem cell therapy, the dr…
Read More
0
